Early Diagnosis and Treatment of Cardiac Amyloidosis by Screening Biopsy During Trigger Finger Release
2024

Early Diagnosis and Treatment of Cardiac Amyloidosis During Trigger Finger Release

Sample size: 1 publication Evidence: low

Author Information

Author(s): Gibson Ella MD, Ebong Imo A. MD, MS, Darrow Morgan A. MD, Xiong Ge MD, PhD, Lipira Angelo B. MD, MA, Sood Ravi F. MD, MS

Primary Institution: University of California Davis

Hypothesis

Screening for amyloidosis during trigger release surgery may facilitate early diagnosis and treatment of cardiac amyloidosis.

Conclusion

The case supports the potential role of amyloidosis screening during trigger release and highlights the benefits of collaboration between hand surgeons and amyloidosis specialists.

Supporting Evidence

  • The patient was diagnosed with cardiac amyloidosis from a biopsy taken during surgery.
  • The patient was started on disease-modifying therapy and remains asymptomatic.
  • Existing data suggest that older age and multiple trigger digits are risk factors for amyloidosis.

Takeaway

Doctors can find heart problems called amyloidosis when they do surgery on fingers, which helps treat the heart early.

Methodology

A biopsy was performed during trigger release surgery to evaluate for amyloidosis.

Potential Biases

Potential sampling error may lead to false-negative biopsies.

Limitations

The role of screening for amyloidosis during trigger release has yet to be defined due to limitations in existing studies.

Participant Demographics

A 71-year-old right hand–dominant white male engineer.

Digital Object Identifier (DOI)

10.1016/j.jhsg.2024.07.013

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication